Millipore

Lycera names Paul Sekhri president and CEO

Thursday, February 5, 2015

Lycera, a biopharmaceutical company developing breakthrough medicines to treat cancer and autoimmune disease, has named Paul Sekhri president, CEO and a member of the board of directors, effective immediately. Sekhri brings more than 25 years of operational experience in the life sciences industry, including business development and strategy, general management, drug development, and commercial strategy.  He succeeds Kathleen M. Metters, Ph.D., who currently serves as senior advisor to the company.

[Read More]

Madaus joins Quanterix as CEO

Monday, September 19, 2011

Quanterix has named Martin D. Madaus, Ph.D. chief executive officer. Madaus, who also retains his position as chairman, brings more than 20 years of experience in the diagnostics and life science industries, most recently serving as president, chairman and CEO of Millipore, acquired by Merck

[Read More]